Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayode Ogungbenro

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
European Journal of Clinical Pharmacology|May 17, 2008
How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approachKayode Ogungbenro, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|March 22, 2014
Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexateKayode Ogungbenro, Leon Aarons,
Journal of Biopharmaceutical Statistics|January 8, 2009
An effective approach for obtaining optimal sampling windows for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons
Journal of Biopharmaceutical Statistics|August 20, 2010
Sample size/power calculations for population pharmacodynamic experiments involving repeated-count measurementsKayode Ogungbenro, Leon Aarons
British Journal of Clinical Pharmacology|January 24, 2015
Physiologically based pharmacokinetic model for 6-mercpatopurine: exploring the role of genetic polymorphism in TPMT enzyme activityKayode Ogungbenro, Leon Aarons,
Basic & Clinical Pharmacology & Toxicology|January 28, 2010
Optimal design of pharmacokinetic studiesLeon Aarons, Kayode Ogungbenro
Journal of Biopharmaceutical Statistics|April 6, 2006
Sample size calculations based on generalized estimating equations for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons, Gordon Graham
Pharmaceutical Statistics|November 15, 2008
Application of optimal design methodologies in clinical pharmacology experimentsKayode Ogungbenro, Aristides Dokoumetzidis, Leon Aarons
The AAPS Journal|November 22, 2014
Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptyingKayode Ogungbenro, Henry Pertinez, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|August 2, 2015
Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokineticsThierry Wendling, Swati Dumitras, Kayode Ogungbenro, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Clinical Pharmacology|May 17, 2008
How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approachKayode Ogungbenro, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|March 22, 2014
Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexateKayode Ogungbenro, Leon Aarons,
Journal of Biopharmaceutical Statistics|January 8, 2009
An effective approach for obtaining optimal sampling windows for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons
Journal of Biopharmaceutical Statistics|August 20, 2010
Sample size/power calculations for population pharmacodynamic experiments involving repeated-count measurementsKayode Ogungbenro, Leon Aarons
British Journal of Clinical Pharmacology|January 24, 2015
Physiologically based pharmacokinetic model for 6-mercpatopurine: exploring the role of genetic polymorphism in TPMT enzyme activityKayode Ogungbenro, Leon Aarons,
Basic & Clinical Pharmacology & Toxicology|January 28, 2010
Optimal design of pharmacokinetic studiesLeon Aarons, Kayode Ogungbenro
Journal of Biopharmaceutical Statistics|April 6, 2006
Sample size calculations based on generalized estimating equations for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons, Gordon Graham
Pharmaceutical Statistics|November 15, 2008
Application of optimal design methodologies in clinical pharmacology experimentsKayode Ogungbenro, Aristides Dokoumetzidis, Leon Aarons
The AAPS Journal|November 22, 2014
Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptyingKayode Ogungbenro, Henry Pertinez, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|August 2, 2015
Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokineticsThierry Wendling, Swati Dumitras, Kayode Ogungbenro, et al.
Pageof 10